Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

275 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Monoclonal antibody therapy of ovarian cancer.
Nicodemus CF, Berek JS. Nicodemus CF, et al. Among authors: berek js. Expert Rev Anticancer Ther. 2005 Feb;5(1):87-96. doi: 10.1586/14737140.5.1.87. Expert Rev Anticancer Ther. 2005. PMID: 15757441 Review.
Specific keynote: immunological therapy for ovarian cancer.
Berek JS, Dorigo O, Schultes B, Nicodemus C. Berek JS, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S105-9; discussion S110-3. doi: 10.1006/gyno.2002.6695. Gynecol Oncol. 2003. PMID: 12586097 Review. No abstract available.
Intraperitoneal chemotherapy for ovarian cancer.
Hamilton CA, Berek JS. Hamilton CA, et al. Among authors: berek js. Curr Opin Oncol. 2006 Sep;18(5):507-15. doi: 10.1097/01.cco.0000239892.21161.18. Curr Opin Oncol. 2006. PMID: 16894301 Review.
Abagovomab for ovarian cancer.
Pfisterer J, Harter P, Simonelli C, Peters M, Berek J, Sabbatini P, du Bois A. Pfisterer J, et al. Expert Opin Biol Ther. 2011 Mar;11(3):395-403. doi: 10.1517/14712598.2011.553598. Epub 2011 Jan 18. Expert Opin Biol Ther. 2011. PMID: 21241213 Review.
275 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page